Roflumilast foam, 0.3 percent effective in patients with severe allergic reactions who are intolerant to steroids.

Published Date: 18 Jan 2024

New findings from the 2024 Winter Clinical Dermatology Conference showed that patients with seborrheic dermatitis who did not respond well to treatment or who were intolerant to steroids had a 3 point 5 times higher chance of achieving Investigator Global Assessment (IGA) success with roflumilast foam compared to vehicle.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Psychedelic Therapy Tied to Reduced Depression, Anxiety.

2.

New drug resistance mechanism in melanoma leptomeningeal disease revealed by study.

3.

Research finds stark disparities in treatment and survival time for people with pancreatic cancer

4.

Tumor characteristics found to differ for melanomas in children, teens and young adults

5.

Relationship-building key to addressing oncologist shortages in rural care


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot